Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

164
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
164
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

464
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
464
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

183
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
183
Stimulants01:29

Stimulants

186
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
186
Drug Dependence01:17

Drug Dependence

1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

275
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
275

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Initial Survey Assessing the Temporal Relationship of Kratom Initiation With Medical Treatment and Substance Use.

Substance use : research and treatment·2026
Same author

Misuse of Pregabalin and Gabapentin: A Second Systematic Review Update.

Drugs·2026
Same author

Comment on "Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy".

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Embracing Pharmacists' Opportunities to Improve Care for People Living With Substance Use Disorders.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Indole Alkaloids as Biased Opioid Receptor Modulators.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Increasing Buprenorphine and Naloxone Access in Texas Community Pharmacies Through an Academic Detailing Intervention.

Substance use & addiction journal·2026

Related Experiment Video

Updated: Jun 24, 2025

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

11.6K

Kratom as a potential substance use disorder harm reduction agent.

MeShell Green1, Nina Vadiei2,3, Charles A Veltri1

  • 1Midwestern University College of Pharmacy, Glendale, AZ, United States.

Frontiers in Public Health
|June 14, 2024
PubMed
Summary

Kratom, an herbal substance, shows potential for harm reduction in substance use disorders, offering opioid and stimulant-like effects. Further research is needed to explore its therapeutic benefits and address safety concerns for conditions like opioid, alcohol, and stimulant use disorders.

Keywords:
Mitragyna speciosaalcohol use disorderharm reductionkratommitragynineopioid use disorderstimulant use disordersubstance use disorder

More Related Videos

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.2K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.2K

Related Experiment Videos

Last Updated: Jun 24, 2025

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

11.6K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.2K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.2K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Public Health

Background:

  • Substance use disorders (SUDs) are a major public health issue in the U.S., with limited treatment access and options for certain types of SUDs.
  • Existing pharmacotherapies are effective for opioid and alcohol use disorders, but patient barriers like stigma and desire for less restrictive use hinder treatment engagement.
  • Stimulant and polysubstance use disorders have particularly limited treatment avenues, highlighting the need for novel harm reduction strategies.

Purpose of the Study:

  • To review the history of kratom (Mitragyna speciosa Korth.) use.
  • To examine kratom's pharmacology and preclinical/observational research for therapeutic potential in various substance use disorders.
  • To highlight current concerns and future research directions regarding kratom for harm reduction.

Main Methods:

  • Literature review of historical use, pharmacology, preclinical studies, and observational research on kratom.
  • Analysis of kratom's potential role in managing opioid, alcohol, stimulant, and polysubstance use disorders.
  • Identification of safety concerns, regulatory issues, and knowledge gaps.

Main Results:

  • Kratom exhibits both opioid and stimulant-like effects, with historical use in Southeast Asia for medicinal purposes.
  • Early research suggests potential therapeutic applications for kratom in managing withdrawal and cravings associated with various SUDs.
  • Concerns exist regarding kratom's adverse effects, dependence potential, and lack of standardized manufacturing and regulation.

Conclusions:

  • Kratom presents a potential harm reduction tool for substance use disorders, warranting further investigation.
  • Additional rigorous research is essential to establish efficacy, safety, and optimal use protocols for kratom.
  • Addressing regulatory and manufacturing standards is crucial for responsible integration of kratom into harm reduction strategies.